XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Series A Preferred Shares
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Non-controlling Interest
Beginning balance, value at Dec. 31, 2019 $ 76,678   $ 24 $ 149,840 $ (75,686) $ 2,500
Beginning balance, shares at Dec. 31, 2019     28,686,116      
Issuance of common stock, shares     1,208,169      
2020 Private Placement shares, net of costs 12,115     12,115    
2020 Private Placement shares, net of costs, shares   660,000 2,300,000      
2020 Private Placement Warrants, net of costs 4,621     4,621    
Beneficial conversion feature 3,564     3,564    
Dividends from subsidiaries (218)         (218)
Net income (loss) - the Company (50,190)       (50,190)  
Net loss - non-controlling interest (513)         (513)
Stock-based compensation 517     517    
Ending balance, value at Mar. 31, 2020 46,574   $ 24 170,657 (125,876) 1,769
Ending balance, shares at Mar. 31, 2020   660,000 32,194,285      
Beginning balance, value at Dec. 31, 2019 76,678   $ 24 149,840 (75,686) 2,500
Beginning balance, shares at Dec. 31, 2019     28,686,116      
Net loss - non-controlling interest (690)          
Ending balance, value at Jun. 30, 2020 40,334   $ 25 174,622 (135,464) 1,151
Ending balance, shares at Jun. 30, 2020     39,830,122      
Beginning balance, value at Mar. 31, 2020 46,574   $ 24 170,657 (125,876) 1,769
Beginning balance, shares at Mar. 31, 2020   660,000 32,194,285      
Options exercised 34     34    
Options exercised, shares     22,777      
Issuance of common stock 3,393     3,393    
Issuance of common stock, shares     1,013,060      
Conversion of Preferred Stock Series A     $ 1 (1)    
Conversion of Preferred Stock Series A, shares   (660,000) 6,600,000      
Beneficial conversion feature (3,564)     (3,564)    
Deemed dividend 3,564     3,564    
Disposal of subsidiary (441)         (441)
Net income (loss) - the Company (9,588)       (9,588)  
Net loss - non-controlling interest (177)         (177)
Stock-based compensation 539     539    
Ending balance, value at Jun. 30, 2020 40,334   $ 25 174,622 (135,464) 1,151
Ending balance, shares at Jun. 30, 2020     39,830,122      
Beginning balance, value at Dec. 31, 2020 43,761   $ 26 201,598 (157,392) (471)
Beginning balance, shares at Dec. 31, 2020     53,551,126      
December 2020 Public Offering warrants exercise 903     903    
December 2020 Public Offering warrants exercise, shares     361,200      
Options exercised 212     212    
Options exercised, shares     157,304      
Net income (loss) - the Company (9,259)       (9,259)  
Net loss - non-controlling interest (176)         (176)
Stock-based compensation 508     508    
Ending balance, value at Mar. 31, 2021 35,949   $ 26 203,221 (166,651) (647)
Ending balance, shares at Mar. 31, 2021     54,069,630      
Beginning balance, value at Dec. 31, 2020 $ 43,761   $ 26 201,598 (157,392) (471)
Beginning balance, shares at Dec. 31, 2020     53,551,126      
Options exercised, shares 229,496          
Net loss - non-controlling interest $ (311)          
Ending balance, value at Jun. 30, 2021 36,847   $ 26 203,877 (166,274) (782)
Ending balance, shares at Jun. 30, 2021     54,141,822      
Beginning balance, value at Mar. 31, 2021 35,949   $ 26 203,221 (166,651) (647)
Beginning balance, shares at Mar. 31, 2021     54,069,630      
Options exercised 98     98    
Options exercised, shares     72,192      
Net income (loss) - the Company 377       377  
Net loss - non-controlling interest (135)         (135)
Stock-based compensation 558     558    
Ending balance, value at Jun. 30, 2021 $ 36,847   $ 26 $ 203,877 $ (166,274) $ (782)
Ending balance, shares at Jun. 30, 2021     54,141,822